Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 1
2006 3
2007 5
2008 4
2009 4
2010 3
2011 7
2012 2
2013 5
2014 3
2015 4
2016 8
2017 4
2018 4
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Alcohol and Hypertension-New Insights and Lingering Controversies.
Puddey IB, Mori TA, Barden AE, Beilin LJ. Puddey IB, et al. Among authors: barden ae. Curr Hypertens Rep. 2019 Sep 7;21(10):79. doi: 10.1007/s11906-019-0984-1. Curr Hypertens Rep. 2019. PMID: 31494743 Review.
Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice.
Martinsen A, Tejera N, Vauzour D, Harden G, Dick J, Shinde S, Barden A, Mori TA, Minihane AM. Martinsen A, et al. Among authors: barden a. FASEB J. 2019 Sep;33(9):10315-10326. doi: 10.1096/fj.201900423R. Epub 2019 Jul 29. FASEB J. 2019. PMID: 31251078
The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
Barden AE, Shinde S, Burke V, Puddey IB, Beilin LJ, Irish AB, Watts GF, Mori TA. Barden AE, et al. Prostaglandins Other Lipid Mediat. 2018 May;136:1-8. doi: 10.1016/j.prostaglandins.2018.03.002. Epub 2018 Mar 22. Prostaglandins Other Lipid Mediat. 2018. PMID: 29577973 Clinical Trial.
Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA. Barden AE, et al. Prostaglandins Leukot Essent Fatty Acids. 2016 Apr;107:24-9. doi: 10.1016/j.plefa.2016.03.004. Epub 2016 Mar 9. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 27033423
The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
Barden A, Shinde S, Phillips M, Beilin L, Mas E, Hodgson JM, Puddey I, Mori TA. Barden A, et al. Prostaglandins Leukot Essent Fatty Acids. 2018 Jun;133:29-34. doi: 10.1016/j.plefa.2018.04.004. Epub 2018 Apr 26. Prostaglandins Leukot Essent Fatty Acids. 2018. PMID: 29789130 Free article. Clinical Trial.
n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
Barden A, O'Callaghan N, Burke V, Mas E, Beilin LJ, Fenech M, Irish AB, Watts GF, Puddey IB, Huang RC, Mori TA. Barden A, et al. Nutrients. 2016 Mar 19;8(3):175. doi: 10.3390/nu8030175. Nutrients. 2016. PMID: 27007392 Free PMC article. Clinical Trial.
Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers.
Barden A, Phillips M, Hill LM, Fletcher EM, Mas E, Loh PS, French MA, Ho KM, Mori TA, Corcoran TB. Barden A, et al. Prostaglandins Leukot Essent Fatty Acids. 2018 Dec;139:31-39. doi: 10.1016/j.plefa.2018.11.004. Epub 2018 Nov 8. Prostaglandins Leukot Essent Fatty Acids. 2018. PMID: 30471772 Clinical Trial.
Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA. See VHL, et al. Among authors: barden ae. Br J Nutr. 2017 Dec;118(11):971-980. doi: 10.1017/S0007114517002914. Epub 2017 Nov 27. Br J Nutr. 2017. PMID: 29173199 Clinical Trial.
Evaluation of biomarkers of kidney injury following 4% succinylated gelatin and 6% hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model.
Boyd CJ, Claus MA, Raisis AL, Cianciolo R, Bosio E, Hosgood G, Nabity M, Mori T, Barden A, Sharp CR, Smart L. Boyd CJ, et al. Among authors: barden a. J Vet Emerg Crit Care (San Antonio). 2019 Mar;29(2):132-142. doi: 10.1111/vec.12814. Epub 2019 Feb 14. J Vet Emerg Crit Care (San Antonio). 2019. PMID: 30767375
A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
Mas E, Barden A, Burke V, Beilin LJ, Watts GF, Huang RC, Puddey IB, Irish AB, Mori TA. Mas E, et al. Among authors: barden a. Clin Nutr. 2016 Apr;35(2):331-336. doi: 10.1016/j.clnu.2015.04.004. Epub 2015 Apr 13. Clin Nutr. 2016. PMID: 25908532 Free article. Clinical Trial.
59 results
Jump to page
Feedback